By: IPP Bureau
Last updated : June 08, 2021 11:19 am
The company also plans to register the similar range of products in the neighbouring countries.
Vaishali Pharma Limited has initiated registration of 30 products in the Central African Countries with the portfolio of antibiotics, sedatives, anti-malaria, anti-inflammatory, painkillers and multivitamins.
These products have a good demand in the markets of Central African Countries. The company also plans to register the similar range of products in the neighbouring countries.
The value of Africa’s pharmaceutical industry jumped to US $20.8 billion in 2013 from just US $4.7 billion a decade earlier. This growth is constantly progressing at a rapid pace and experts predict that the market will be worth US $40 billion to US $65 billion by 2020 and so on.
Atul Arvind Vasani, Chairman and Managing Director, Vaishali Pharma Limited said, “The company has initiated with the registration of 30 products in the Central African Countries with the portfolio of antibiotics, sedatives, antimalaria, anti inflammatory, painkillers and is yet another important step towards laying a strong foundation and meeting our desired targets. Our company is in a phase of evolution and growth and we will strive hard and deliver on the expected lines."